Cargando…
Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
Unprecedented breakthroughs have been made in cancer immunotherapy in recent years. Particularly immune checkpoint inhibitors have fostered hope for patients with cancer. However, immunotherapy still exhibits certain limitations, such as a low response rate, limited efficacy in certain populations,...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258331/ https://www.ncbi.nlm.nih.gov/pubmed/37313405 http://dx.doi.org/10.3389/fimmu.2023.1199631 |